Evidence map›Paper›PMID 21570031›Full record

ArticlePM & R : the journal of injury, function, and rehabilitation2011

Systemic inflammation and reduced pulmonary function in chronic spinal cord injury.

Eric Garshick, Kelly L Stolzmann, David R Gagnon, Leslie R Morse, Robert Brown

Abstract read
In one paragraph

Article in PM & R : the journal of injury, function, and rehabilitation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. HAntioxidants (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. SIRT1: A promising therapeutic target for chronic pain.CNS neuroscience & therapeutics · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Observational
  11. FEVBMC pulmonary medicine · 2017
    Article
  12. Inflammatory Stress Effects on Health and Function After Spinal Cord Injury.Topics in spinal cord injury rehabilitation · 2017
    Review
  13. Article
  14. Review
  15. Article
  16. Protective effects of Vitamin C against spinal cord injury-induced renal damage through suppression of NF-κB and proinflammatory cytokines.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2015
    Article
  17. Resveratrol attenuates spinal cord injury-induced inflammatory damage in rat lungs.International journal of clinical and experimental pathology · 2015
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eric GarshickPulmonary and Critical Care Medicine Section, Medical Service, VA Boston Healthcare System, 1400 VFW Parkway, West Roxbury, MA 02132, USA. eric.garshick@va.gov
Kelly L Stolzmann
David R Gagnon
Leslie R Morse
Robert Brown

Funding

Respiratory Function and Illness in Spinal Cord InjuryR01HD042141 · NICHD · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GARSHICK, ERIC · 2002 to 2006
$1.9M
NICHD NIH HHS R01 HD042141
6 · The paper itself

Abstract

objectiveTo evaluate the relationship between systemic inflammation and pulmonary function in persons with chronic spinal cord injury (SCI).

designCross-sectional study.

settingVeterans Affairs Medical Center.

participantsFifty-nine men with chronic SCI participating in a prior epidemiologic study.

methodsStandardized assessment of pulmonary function and measurement of plasma C-reactive protein (CRP) and interleukin-6 (IL-6). MAIN OUTCOME MEASUREMENTS: Forced expiratory volume in 1 second (FEV(1)) and forced vital capacity (FVC).

resultsPersons with the highest values of IL-6 had the lowest %-predicted FEV(1) and FVC. There was a significant inverse linear trend between quartile of IL-6 and %-predicted FEV(1) (P < .001) and FVC (P < .006), unadjusted and adjusted for SCI level and completeness of injury, obstructive lung disease history, smoking, and body mass index (P = .010-.039). Although not as strong as for IL-6, there also were similar trends for %-predicted FEV(1) and FVC with CRP.

conclusionsIn chronic SCI, higher levels of IL-6 and CRP were associated with a lower FEV(1) and FVC, independent of level and completeness of injury. These results suggest that the reduction of pulmonary function after SCI is related not only to neuromuscular impairment but also to factors that promote systemic inflammation.

Indexed as

AdultAgedChronic DiseaseC-Reactive ProteinCross-Sectional StudiesFemaleForced Expiratory VolumeHumansInflammationInterleukin-6LungMaleMiddle AgedParaplegiaSpinal Cord InjuriesVital CapacityC-Reactive ProteinInterleukin-6

Identifiers

PMID21570031
PMCPMC3141080

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.